Gf Fund Management Co. Ltd. Avidity Biosciences, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 3,055 shares of RNA stock, worth $89,542. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,055
Previous 2,505
21.96%
Holding current value
$89,542
Previous $72.8 Million
23.8%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RNA
# of Institutions
244Shares Held
116MCall Options Held
289KPut Options Held
998K-
Janus Henderson Group PLC London, X011.4MShares$335 Million0.19% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.3MShares$332 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$284 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.24MShares$271 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.75MShares$256 Million4.23% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.53B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...